Please log in to see the full text of this API!
Abacavir
-
Synonyms:
1592U89
-
ATC:
J05AF06
-
Use:
Lorem
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:286.34 g/mol
-
CAS-RN:136470-78-5
-
InChI Key:MCGSCOLBFJQGHM-SCZZXKLOSA-N
-
InChI:InChI=1S/C14H18N6O/c15-14-18-12(17-9-2-3-9)11-13(19-14)20(7-16-11)10-4-1-8(5-10)6-21/h1,4,7-10,21H,2-3,5-6H2,(H3,15,17,18,19)/t8-,10+/m1/s1
Derivatives
succinate
-
Formula:
C14H18N6O • C4H6O
-
MW:356.43 g/mol
-
CAS-RN:168146-84-7
sulfate
-
Formula:
C14H18N6O • 1/2H2SO4
-
MW:670.76 g/mol
-
CAS-RN:188062-50-2
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
14036-06-7 |
C7H14O4 |
acetic acid diethoxymethyl ester |
Methanol, diethoxy-, acetate |
108-24-7 |
C4H6O3 |
acetic anhydride |
Acetic acid, anhydride |
51471-45-5 |
C6H5ClN4O4 |
2-acetylamino-6-chloro-5-nitro-4(3H)-pyrimidinone |
Acetamide, N-(6-chloro-1,4-dihydro-5-nitro-4-oxo-2-pyrimidinyl)- |
107-02-8 |
C3H4O |
acrolein |
2-Propenal |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
,1999 |
|
F |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
|
J |
Lorem |
Lorem
|
comb. lamivudine |
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
|
comb. with lamivudine |
Lorem |
Lorem
|
comb. with lamivudine and zidovudine |
Lorem |
Lorem
|
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinviduntutlaboreetdoloremagnaaliquyamerat,seddiamvoluptua.At
References
-
- US 9 999 999 (Burroughs Wellcome; 18.2.1992; GB-prior. 27.6.1988).
- a EP 999 999 (Wellcome Found.; 26.6.1991; appl. 21.12.1990; USA-prior. 22.12.1989).
- Crimmins, M.T. et al.: J. Org. Chem. (JOCEAH) 61 9999 (1996).
- EP 9 999 999 (Solmag; appl. 5.5.2006).
- aa EP 999 999 (Enzymatix; appl. 24.4.1991; GB-prior. 16.10.1989).
- US 9 999 999 (SmithKline Beecham; 22.1.2002; appl. 20.8.1998; GB-prior. 22.8.1997).
- b Olivo, H.F. et al.: J. Chem. Soc., Perkin Trans. 9 (JCPRB4) 1998, 391.
- c US 9 999 999 (Welcome Found.; 23.7.1991; appl. 22.12.1989; GB-prior. 27.6.1988).
- d WO 9 999 999 (Glaxo; appl. 12.11.1998; WO-prior. 12.11.1997).
-
alternative syntheses:
- EP 999 999 (Lonza; appl. 13.5.1998; CH-prior. 13.5.1997).
-
preparation of chloropyrimidine intermediate V:
- US 9 999 999 (SmithKline Beecham; 10.9.2002; appl. 3.2.1995; GB-prior. 4.2.1994).
-
condensation of pyrimidines with cyclopentylamine IV:
- Vince, R.; Hua, M.: J. Med. Chem. (JMCMAR) 33 (1), 99 (1990).
- EP 999 999 (Wellcome Found.; appl. 26.6.1989; GB-prior. 27.6.1988).
- EP 999 999 (Wellcome Found.; appl. 23.10.1989; GB-prior. 24.10.1988).
- Grumam, A. et al.: Tetrahedron Lett. (TELEAY) 36 (42), 9999 (1995).
- US 9 999 999 (SmithKline Beecham; 11.11.2003; appl. 14.10.1998; GB-prior. 14.10.1997).
- JP 9 999 999 (Asahi Glass Co.; appl. 17.7.1987).
-
alternative preparation of 4-amino-2-cyclopentene-1-methanol:
- EP 999 999 (Lonza; appl. 24.11.1998; CH-prior. 27.11.1997).
- WO 9 999 999 (Lonza; appl. 30.5.1997; CH-prior. 30.5.1996).
- WO 9 999 999 (Glaxo; 4.3.1999; GB-prior. 20.8.1998).
- WO 9 999 999 (Glaxo; 11.6.1998; GB-prior. 7.12.1996).
- WO 9 999 999 999 (Chirotech; 15.3.2001; GB-prior. 9.9.1999).
-
abacavir hemisulfate salt:
- US 9 999 999 (Glaxo Wellcome; 25.9.2001; appl. 14.5.1998; GB-prior. 17.5.1997).
-
abacavir succinate as antiviral agent:
- WO 9 999 999 (Wellcome; 7.3.1996; appl. 25.8.1995; GB-prior. 26.8.1994).
-
pharmaceutical formulations:
- US 9 999 999 (SmithKline Beecham; 4.11.2003; appl. 4.2.1999; GB-prior. 6.2.1998).
-
synergistic combinations for treatment of HIV infection:
- WO 9 999 999 (Wellcome; 3.10.1996; appl. 28.3.1996; GB-prior. 30.3.1995).